Zonggui Wu

2.5k total citations
67 papers, 1.9k citations indexed

About

Zonggui Wu is a scholar working on Cardiology and Cardiovascular Medicine, Immunology and Molecular Biology. According to data from OpenAlex, Zonggui Wu has authored 67 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cardiology and Cardiovascular Medicine, 23 papers in Immunology and 14 papers in Molecular Biology. Recurrent topics in Zonggui Wu's work include Atherosclerosis and Cardiovascular Diseases (21 papers), Adipokines, Inflammation, and Metabolic Diseases (8 papers) and Cell Adhesion Molecules Research (6 papers). Zonggui Wu is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (21 papers), Adipokines, Inflammation, and Metabolic Diseases (8 papers) and Cell Adhesion Molecules Research (6 papers). Zonggui Wu collaborates with scholars based in China, United States and Sweden. Zonggui Wu's co-authors include Chun Liang, Zhiqing He, Yusheng Ren, Gao-zhong Huang, Zhimin Liu, Yan Sun, Jiaoyang Zheng, Kong Xiantao, Jinchuan Yan and Jianxiang Wu and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Zonggui Wu

64 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zonggui Wu China 21 625 435 297 287 203 67 1.9k
Hongxia Wang China 27 653 1.0× 346 0.8× 290 1.0× 201 0.7× 242 1.2× 90 1.8k
Meng‐Yu Wu Taiwan 18 842 1.3× 230 0.5× 327 1.1× 316 1.1× 432 2.1× 112 2.6k
Carlos Martı́nez-Salgado Spain 28 959 1.5× 321 0.7× 167 0.6× 150 0.5× 209 1.0× 95 2.6k
Georgia Vogiatzi Greece 18 515 0.8× 504 1.2× 226 0.8× 154 0.5× 304 1.5× 83 2.0k
Hai‐Lu Zhao China 28 734 1.2× 355 0.8× 170 0.6× 236 0.8× 557 2.7× 79 2.6k
Anil Bhanudas Gaikwad India 29 908 1.5× 372 0.9× 133 0.4× 156 0.5× 257 1.3× 110 2.3k
Cuntai Zhang China 25 1.0k 1.6× 415 1.0× 264 0.9× 312 1.1× 218 1.1× 148 2.1k
Roberto Antonicelli Italy 27 962 1.5× 811 1.9× 366 1.2× 603 2.1× 364 1.8× 111 3.0k
Gloria Formoso Italy 27 661 1.1× 385 0.9× 286 1.0× 128 0.4× 297 1.5× 59 2.2k
Sherene M. Shenouda United States 13 576 0.9× 370 0.9× 129 0.4× 107 0.4× 148 0.7× 15 1.7k

Countries citing papers authored by Zonggui Wu

Since Specialization
Citations

This map shows the geographic impact of Zonggui Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zonggui Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zonggui Wu more than expected).

Fields of papers citing papers by Zonggui Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zonggui Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zonggui Wu. The network helps show where Zonggui Wu may publish in the future.

Co-authorship network of co-authors of Zonggui Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Zonggui Wu. A scholar is included among the top collaborators of Zonggui Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zonggui Wu. Zonggui Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Zhanqing, et al.. (2025). A Sub-Nanosecond Delay Floating Voltage Level Shifter With 300 V/ns Power Supply Slew Tolerance. IEEE Transactions on Circuits and Systems I Regular Papers. 72(11). 6762–6771.
2.
Niu, Wenhao, Feng Wu, Wenyue Cao, et al.. (2020). Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6. Bioscience Reports. 41(1). 83 indexed citations
3.
Niu, Wenhao, Feng Wu, Wenyue Cao, et al.. (2020). Network Pharmacology Analysis to Identify Phytochemicals in Traditional Chinese Medicines That May Regulate ACE2 for the Treatment of COVID‐19. Evidence-based Complementary and Alternative Medicine. 2020(1). 7493281–7493281. 33 indexed citations
4.
Cao, Zhiyong, Ping Zhang, Zhiqing He, et al.. (2016). Obstructive sleep apnea combined dyslipidemia render additive effect on increasing atherosclerotic cardiovascular diseases prevalence. Lipids in Health and Disease. 15(1). 98–98. 9 indexed citations
5.
Ding, Ru, Zhiqing He, Haibing Wang, et al.. (2015). Overrepresentation of Th1- and Th17-like Follicular Helper T Cells in Coronary Artery Disease. Journal of Cardiovascular Translational Research. 8(9). 503–505. 14 indexed citations
6.
Shen, Ying, Feng Wu, Qi Zhang, et al.. (2014). Clinical relevance of angiographic coronary collaterals during primary coronary intervention for acute ST-elevation myocardial infarction. Chinese Medical Journal. 127(1). 66–71. 8 indexed citations
7.
Ren, Yusheng, et al.. (2012). High-Altitude Pulmonary Edema Is Associated With Coagulation and Fibrinolytic Abnormalities. The American Journal of the Medical Sciences. 344(3). 186–189. 7 indexed citations
8.
Chen, Tao, et al.. (2011). Myelodysplastic syndrome associated with clopidogrel: a case report. International Journal of Clinical Pharmacology and Therapeutics. 50(1). 44–46.
9.
Ren, Yusheng, et al.. (2010). Incidence of High Altitude Illnesses among Unacclimatized Persons Who Acutely Ascended to Tibet. High Altitude Medicine & Biology. 11(1). 39–42. 47 indexed citations
10.
Chen, Tao, Tao Xu, Yang Li, et al.. (2010). Risk of cardiac dysfunction with trastuzumab in breast cancer patients: A meta-analysis. Cancer Treatment Reviews. 37(4). 312–320. 95 indexed citations
11.
Wu, Zonggui. (2009). Therapeutic angiogenesis: The combination point of Chinese and western medicine in prevention and treatment of ischemic heart disease. Chinese Journal of Integrative Medicine. 15(5). 323–324. 4 indexed citations
12.
Jiang, Hailong, Chun Liang, Xing Liu, et al.. (2009). Palmitic acid promotes endothelial progenitor cells apoptosis via p38 and JNK mitogen-activated protein kinase pathways. Atherosclerosis. 210(1). 71–77. 51 indexed citations
13.
Liang, Chun, Yusheng Ren, Zhen Yi, et al.. (2008). Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways. Basic Research in Cardiology. 104(1). 42–49. 139 indexed citations
14.
Wu, Zonggui. (2007). Tongxinluo inhibits formation of vascular adventitia damage-induced atherosclerotic plaques and CD40 expression in rabbits. 1 indexed citations
15.
Wu, Zonggui, et al.. (2007). American ginseng modulates pancreatic beta cell activities. Chinese Medicine. 2(1). 11–11. 15 indexed citations
16.
Ohishi, Mitsuru, Norihisa Ito, Ken Sugimoto, et al.. (2006). Genetic Influences of .BETA.-Adrenoceptor Polymorphisms on Arterial Functional Changes and Cardiac Remodeling in Hypertensive Patients. Hypertension Research. 29(11). 875–881. 14 indexed citations
17.
Wu, Zonggui. (2005). Macrophage and Atherosclerosis. 2 indexed citations
18.
Yan, Jinchuan, et al.. (2005). Increased levels of CD40–CD40 ligand system in patients with essential hypertension. Clinica Chimica Acta. 355(1-2). 191–196. 24 indexed citations
19.
Wu, Zonggui, et al.. (2004). Change of cardiac matrix metalloproteinases during the progression of left ventricalar remodeling in a rat mod el of acute myocardial infarction. 27(9). 670–673. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026